{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:54:09Z","timestamp":1787684049282,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.nmd.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:52:31Z","timestamp":1676289151000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Urine titin as a novel biomarker for Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1910-0445","authenticated-orcid":false,"given":"Misawa Niki","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kuboki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Quinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2023.02.003_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Aartsma-Rus A. Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"18","key":"10.1016\/j.nmd.2023.02.003_bib0002","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1074\/jbc.R200031200","article-title":"Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function","volume":"278","author":"Michele","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.nmd.2023.02.003_bib0003","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.nmd.2023.02.003_bib0004","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.02.003_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","article-title":"Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011","volume":"56","author":"Kieny","year":"2013","journal-title":"Ann Phys Rehabil Med"},{"issue":"2","key":"10.1016\/j.nmd.2023.02.003_bib0006","first-page":"117","article-title":"Survival in Duchenne muscular dystrophy","volume":"31","author":"Rall","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2023.02.003_bib0007","series-title":"Becker muscular dystrophy","author":"Thada","year":"2022"},{"issue":"10","key":"10.1016\/j.nmd.2023.02.003_bib0008","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-020-01339-3","article-title":"Viltolarsen: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"issue":"17","key":"10.1016\/j.nmd.2023.02.003_bib0009","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40265-016-0657-1","article-title":"Eteplirsen: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.nmd.2023.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2023.02.003_bib0011","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/acn3.51235","article-title":"Viltolarsen in Japanese Duchenne muscular dystrophy patients: a phase 1\/2 study","volume":"7","author":"Komaki","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"24","key":"10.1016\/j.nmd.2023.02.003_bib0012","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2023.02.003_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5535\/arm.2017.41.2.306","article-title":"Correlation of serum Creatine kinase level with pulmonary function in Duchenne muscular dystrophy","volume":"41","author":"Kim","year":"2017","journal-title":"Ann Rehabil Med"},{"key":"10.1016\/j.nmd.2023.02.003_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2021.09.010","article-title":"Creatine kinase test diagnostic accuracy in neonatal screening for Duchenne Muscular Dystrophy: a systematic review","volume":"98","author":"de Freitas Nakata","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.nmd.2023.02.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J Nutr Metab"},{"issue":"2","key":"10.1016\/j.nmd.2023.02.003_bib0016","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0022-510X(91)90068-I","article-title":"Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy","volume":"102","author":"Zatz","year":"1991","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.nmd.2023.02.003_bib0017","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2217\/epi-2018-0022","article-title":"Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients","volume":"10","author":"Catapano","year":"2018","journal-title":"Epigenomics"},{"issue":"10","key":"10.1016\/j.nmd.2023.02.003_bib0018","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.braindev.2018.06.012","article-title":"Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers","volume":"40","author":"Takeshita","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2023.02.003_bib0019","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphys.2016.00076","article-title":"Titin, a central mediator for hypertrophic signaling, exercise-induced mechanosignaling and skeletal muscle remodeling","volume":"7","author":"Kruger","year":"2016","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.nmd.2023.02.003_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"Rouillon","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2023.02.003_bib0021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ame2.12204","article-title":"A sandwich ELISA kit reveals marked elevation of titin N-terminal fragment levels in the urine of mdx mice","volume":"5","author":"Shirakawa","year":"2022","journal-title":"Anim Model Exp Med"},{"key":"10.1016\/j.nmd.2023.02.003_bib0022","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cca.2018.07.041","article-title":"Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy","volume":"486","author":"Matsuo","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nmd.2023.02.003_bib0023","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2017.11.024","article-title":"Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients","volume":"476","author":"Awano","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.nmd.2023.02.003_bib0024","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2017.05.009","article-title":"Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents","volume":"27","author":"Robertson","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.02.003_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4939-8651-4_14","article-title":"In vivo evaluation of Dystrophin exon skipping in mdx mice","volume":"1828","author":"Wu","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.nmd.2023.02.003_bib0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jgm.603","article-title":"Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays","volume":"6","author":"Graham","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.nmd.2023.02.003_bib0027","article-title":"PPMO-mediated exon skipping induces uniform sarcolemmal dystrophin rescue with dose-dependent restoration of circulating microRNA biomarkers and muscle biophysical properties","author":"Jo","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10.1016\/j.nmd.2023.02.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195850","article-title":"Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy","volume":"13","author":"Beekman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2023.02.003_bib0029","doi-asserted-by":"crossref","first-page":"39375","DOI":"10.1038\/srep39375","article-title":"Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine","volume":"6","author":"Maruyama","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nmd.2023.02.003_bib0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.nmd.2023.02.003_bib0031","doi-asserted-by":"crossref","first-page":"C409","DOI":"10.1152\/ajpcell.00212.2021","article-title":"Murine models of Duchenne muscular dystrophy: is there a best model?","volume":"321","author":"Swiderski","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nmd.2023.02.003_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.647010","article-title":"Abnormal calcium handling in Duchenne muscular dystrophy: mechanisms and potential therapies","volume":"12","author":"Mareedu","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.nmd.2023.02.003_bib0033","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/abbi.1997.0108","article-title":"Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs","volume":"342","author":"Kinbara","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.nmd.2023.02.003_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(99)00095-3","article-title":"Calpains and muscular dystrophies","volume":"32","author":"Tidball","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.nmd.2023.02.003_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis Model Mech"},{"issue":"6335","key":"10.1016\/j.nmd.2023.02.003_bib0036","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nmd.2023.02.003_bib0037","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","article-title":"Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino","volume":"181","author":"Wu","year":"2012","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.nmd.2023.02.003_bib0038","doi-asserted-by":"crossref","first-page":"e69194","DOI":"10.1371\/journal.pone.0069194","article-title":"Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice","volume":"8","author":"Echigoya","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.nmd.2023.02.003_bib0039","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/acn3.319","article-title":"Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy","volume":"3","author":"Godi","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"437","key":"10.1016\/j.nmd.2023.02.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.nmd.2023.02.003_bib0041","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","article-title":"North star ambulatory assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy","volume":"20","author":"Mazzone","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2023.02.003_bib0042","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/psp4.12220","article-title":"Developing a natural history progression model for duchenne muscular dystrophy using the six-minute walk test","volume":"6","author":"Hamuro","year":"2017","journal-title":"CPT Pharmacomet Syst Pharmacol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:47Z","timestamp":1760775167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0960896623000238"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine titin as a novel biomarker for Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}